Patents by Inventor Christopher W. Gregory

Christopher W. Gregory has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for detecting both pre-cancerous and cancerous tissues
    Patent number: 8467865
    Abstract: A method for characterizing tissues within a subject as cancerous or non-cancerous includes determining the electrical properties of the subject. The electrical properties of the subject are fit to a model and a characteristic frequency of each tissue is then calculated. Each tissue is finally characterized as cancerous or non-cancerous if its characteristic frequency lies above a threshold value.
    Type: Grant
    Filed: March 5, 2008
    Date of Patent: June 18, 2013
    Assignee: WiSys Technology Foundation
    Inventors: William D. Gregory, Christopher W. Gregory
  • METHODS FOR TREATING AND PREVENTING CANCERS THAT EXPRESS THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS OF HORMONES AND RECEPTORS
    Publication number: 20110286998
    Abstract: Methods are provided for treating HPG axis-positive cancers, preventing or slowing proliferation of cells of HPG axis-positive cancer origin, preventing HPG axis-positive cancers in a patient at risk of contracting such cancers, preventing or inhibiting an upregulation of the cell cycle in HPG axis-positive cancer-derived cells in a patient, and decreasing the level of HPG axis-positive cancer-specific markers in a patient.
    Type: Application
    Filed: November 19, 2010
    Publication date: November 24, 2011
    Applicant: Voyager Pharmaceutical Corporation
    Inventors: Christopher W. Gregory, Maria E. Kononov, Eric S. Werdin, James Lester Barbee, IV, Carol Giamario
  • TREATMENT OF ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT USING GNRH-I ANALOGS AND ONE OR MORE OF ACETYLCHOLINESTERASE INHIBITORS AND NMDA RECEPTOR ANTAGONISTS
    Publication number: 20110195898
    Abstract: Methods of treating, mitigating, slowing the progression of, or preventing Alzheimer's Disease and Mild Cognitive Impairment (MCI) include administration of gonadotropin-releasing hormone analogs in combination with acetylcholinesterase inhibitors and/or N-methyl-D-aspartate receptor antagonists.
    Type: Application
    Filed: August 30, 2010
    Publication date: August 11, 2011
    Applicant: Voyager Pharmaceutical Corporation
    Inventors: Christopher W. Gregory, Patrick S. Smith
  • Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors
    Publication number: 20090197796
    Abstract: Methods are provided for treating HPG axis-positive cancers, preventing or slowing proliferation of cells of HPG axis-positive cancer origin, preventing HPG axis-positive cancers in a patient at risk of contracting such cancers, preventing or inhibiting an upregulation of the cell cycle in HPG axis-positive cancer-derived cells in a patient, and decreasing the level of HPG axis-positive cancer-specific markers in a patient.
    Type: Application
    Filed: January 11, 2008
    Publication date: August 6, 2009
    Applicant: Voyager Pharmaceutical Corporation
    Inventors: Christopher W. Gregory, Maria E. Kononov, Eric S. Werdin, James Lester Barbee, IV, Carol Giamario
  • METHOD FOR DETECTING BOTH PRE-CANCEROUS AND CANCEROUS TISSUES
    Publication number: 20080221475
    Abstract: A method for characterizing tissues within a subject as cancerous or non-cancerous includes determining the electrical properties of the subject. The electrical properties of the subject are fit to a model and a characteristic frequency of each tissue is then calculated. Each tissue is finally characterized as cancerous or non-cancerous if its characteristic frequency lies above a threshold value.
    Type: Application
    Filed: March 5, 2008
    Publication date: September 11, 2008
    Inventors: William D. Gregory, Christopher W. Gregory
  • Leuprolide acetate and acetylcholinesterase inhibitors/NMDA receptor antagonists for the treatment of alzheimer's disease
    Publication number: 20080214639
    Abstract: Methods of treating, mitigating, slowing the progression of, or preventing Alzheimer's Disease include administration of gonadotropin-releasing hormone analogues in combination with acetylcholinesterase inhibitors and/or N-methyl-D-aspartate receptor antagonists.
    Type: Application
    Filed: August 8, 2007
    Publication date: September 4, 2008
    Applicant: Voyager Pharmaceutical Corporation
    Inventors: Christopher W. Gregory, Patrick S. Smith
  • Treatment of Alzheimer's Disease and Mild Cognitive impairment using GnRH-I analogs and one or more of acetylcholinesterase inhibitors and NMDA receptor antagonists
    Publication number: 20080171736
    Abstract: Methods of treating, mitigating, slowing the progression of, or preventing Alzheimer's Disease and Mild Cognitive Impairment (MCI) include administration of gonadotropin-releasing hormone analogs in combination with acetylcholinesterase inhibitors and/or N-methyl-D-aspartate receptor antagonists.
    Type: Application
    Filed: June 28, 2007
    Publication date: July 17, 2008
    Inventors: Christopher W. Gregory, Patrick S. Smith